Veterinary Medicines

AVIFFA-RTI LIOFILIZADO PARA SUSPENSION OCULONASAL Y PARA ADMINISTRACION EN AGUA DE BEBIDA

Authorised
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
Download as PDF

Product identification

Medicine name:
AVIFFA-RTI LIOFILIZADO PARA SUSPENSION OCULONASAL Y PARA ADMINISTRACION EN AGUA DE BEBIDA
Active substance:
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
Target species:
  • Turkey
  • Chicken (pullet for egg production, future layer)
  • Future breeder pullet
Route of administration:
  • Nebulisation use
  • Ocular use
  • In drinking water use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
    4.00
    50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • Nebulisation use
    • Turkey
      • Meat and offal
        0
        day
    • Chicken (pullet for egg production, future layer)
      • Meat and offal
        0
        day
    • Future breeder pullet
      • Meat and offal
        0
        day
  • Ocular use
    • Turkey
      • Meat and offal
        0
        day
    • Chicken (pullet for egg production, future layer)
      • Meat and offal
        0
        day
    • Future breeder pullet
      • Meat and offal
        0
        day
  • In drinking water use
    • Turkey
      • Meat and offal
        0
        day
    • Chicken (pullet for egg production, future layer)
      • Meat and offal
        0
        day
    • Future breeder pullet
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Espana S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France SCS
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2365 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 13/03/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 13/03/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 13/03/2025
Download